Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.7%

1 terminated out of 27 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

88% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (10)
Early P 1 (1)
P 2 (4)
P 3 (1)
P 4 (1)

Trial Status

Completed7
Recruiting6
Unknown5
Active Not Recruiting3
Not Yet Recruiting3
Terminated1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (27)

Showing 20 of 20 trials
NCT07629830Not ApplicableNot Yet Recruiting

Post Exacerbation Asthma Clinic Telecare Intervention to Reduce Recurrent Exacerbations

NCT07116460Not ApplicableRecruitingPrimary

Cost Effective Air Filtration Intervention in Low-Income Housing to Reduce Asthma Morbidity

NCT07396987Not ApplicableNot Yet RecruitingPrimary

Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation

NCT06734793Recruiting

Wearable Electronic Breath Sound Sensing Device

NCT07129616Recruiting

Remote Monitoring of Asthma in Children and Young People

NCT06201728Not ApplicableEnrolling By Invitation

The Effect of Asthma Flare-up Clinic After Exacerbation

NCT07052942Phase 4Recruiting

Individualizing Treatment for Asthma in Primary Care (Full Study)

NCT05748600Phase 3Active Not Recruiting

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma

NCT05304039Active Not RecruitingPrimary

Phenotyping and Classifying Asthma Exacerbations

NCT07112456Phase 2Not Yet Recruiting

Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations

NCT06377345Not ApplicableRecruiting

Remote Patient Monitoring Solution for Chronic Respiratory Disease Management

NCT06137040Early Phase 1Recruiting

Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation

NCT03277170Phase 2Withdrawn

Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations

NCT05417906Phase 2Active Not RecruitingPrimary

Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations

NCT05013073Not ApplicableTerminated

ASTHMAXcel Emergency Department Study

NCT05603494Not ApplicableUnknownPrimary

The Use of Home Spirometry in the Monitoring of Patients With Acute Exacerbation of Asthma

NCT04941001Not ApplicableCompleted

Optimisation of ASthma In Those With Uncontrolled Symptoms (OASIS)

NCT05908864CompletedPrimary

Nebulized Versus Intravenous Magnesium Sulfate in Treatment of Asthma Exacerbation

NCT05446090UnknownPrimary

Asthma: Phenotyping Exacerbations 3

NCT04501926Unknown

Genomics and Metagenomics of Asthma Severity

Scroll to load more

Research Network

Activity Timeline